1-2 of 2
Vasilios Liapis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo

Alexander H. Staudacher, Yanrui Li, Vasilios Liapis, Jeff Jia Cheng Hou, David Chin, Olan Dolezal, Timothy E. Adams, Patrick H. van Berkel, Michael P. Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (2): 335–345.
https://doi.org/10.1158/1535-7163.MCT-18-0842
Published: 04 February 2019
View article titled, APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective <em>In Vivo</em>
Open the PDF for APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

Irene Zinonos, Agatha Labrinidis, Michelle Lee, Vasilios Liapis, Shelley Hay, Vladimir Ponomarev, Peter Diamond, Andrew C.W. Zannettino, David M. Findlay, Andreas Evdokiou
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2969–2980.
https://doi.org/10.1158/1535-7163.MCT-09-0745
Published: 12 October 2009
View article titled, Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer
Open the PDF for Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer in another window